Clinical trial
Minocycline for the Treatment of Decreased Mental Function in HIV-Infected…
NCT00361257 · Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, Other · Terminated
Key facts
| NCT number | NCT00361257 |
|---|---|
| Title | Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults |
| Official title | Phase II, Randomized, Placebo-Controlled, Double-Blind Study of Minocycline in the Treatment of HIV-Associated Cognitive Impairment |
| Lead sponsor | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, Other |
| Collaborators | National Institute of Allergy and Infectious Diseases (NIAID) NIH Neurologic AIDS Research Consortium (NARC) |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Minocycline, Placebo (Tetracycline) |
| Enrollment | 107 |
| Start date | Mar 1, 2007 |
| Primary completion | Jan 1, 2010 |
| Completion | Jan 1, 2010 |
| First posted | Aug 8, 2006 |
| Last update posted | Feb 5, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: